Related references
Note: Only part of the references are listed.Pronounced antiepileptic activity of the subtype-selective GABAA-positive allosteric modulator PF-06372865 in the GAERS absence epilepsy model
Venceslas Duveau et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Pharmacology in translation: the preclinical and early clinical profile of the novel alpha 2/3 functionally selective GABA(A) receptor positive allosteric modulator PF-06372865
Sarah A. Nickolls et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans
Aurelija Jucaite et al.
PSYCHOPHARMACOLOGY (2017)
The immunohistochemical distribution of the GABAA receptor α1, α2, α3, β2/3 and γ2 subunits in the human thalamus
H. J. Waldvogel et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2017)
Efficacy and tolerability of the modified Atkins diet in young children with refractory epilepsy: Indian experience
Ranju Mehta et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2016)
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085
A. Garcia de Lucas et al.
BIOCHEMICAL PHARMACOLOGY (2015)
EEG-β/γ spectral power elevation in rat: a translatable biomarker elicited by GABAAα2/3-positive allosteric modulators at nonsedating anxiolytic doses
Edward P. Christian et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Understanding Essential Tremor: Progress on the Biological Front
Elan D. Louis
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2014)
Essential tremor: from bedside to bench and back to bedside
Elan D. Louis
CURRENT OPINION IN NEUROLOGY (2014)
Effects of Alprazolam on Cortical Activity and Tremors in Patients with Essential Tremor
Jaime Ibanez et al.
PLOS ONE (2014)
PATTERNS OF mRNA AND PROTEIN EXPRESSION FOR 12 GABAA RECEPTOR SUBUNITS IN THE MOUSE BRAIN
H. Hoertnagl et al.
NEUROSCIENCE (2013)
Re-thinking the biology of essential tremor: From models to morphology
Elan D. Louis
PARKINSONISM & RELATED DISORDERS (2013)
Structure, Function, and Modulation of GABAA Receptors
Erwin Sigel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol
S. L. de Haas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J. R. Atack et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Treatment of patients with essential tremor
Guenther Deuschl et al.
LANCET NEUROLOGY (2011)
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Uwe Rudolph et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
γ-aminobutyrate A receptor, essential tremor, genetics polymorphisms, risk factors
Elena Garcia-Martin et al.
PHARMACOGENETICS AND GENOMICS (2011)
α5GABAA Receptor Activity Sets the Threshold for Long-Term Potentiation and Constrains Hippocampus-Dependent Memory
Loren J. Martin et al.
JOURNAL OF NEUROSCIENCE (2010)
GABAergic Dysfunction in Essential Tremor: An 11C-Flumazenil PET Study
Henning Boecker et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Pharmacological characterization of harmaline-induced tremor activity in mice
Neil E. Paterson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain
G. Munro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy
N. R. Mirza et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
International union of pharmacology.: LXX.: Subtypes of γ-aminobutyric AcidA receptors:: Classification on the basis of subunit composition, pharmacology, and function.: Update
Richard W. Olsen et al.
PHARMACOLOGICAL REVIEWS (2008)
Neuropathological changes in essential tremor: 33 cases compared with 21 controls
Elan D. Louis et al.
BRAIN (2007)
Oscillatory interactions between sensorimotor cortex and the periphery
Stuart N. Baker
CURRENT OPINION IN NEUROBIOLOGY (2007)
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAAα2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers
S. L. de Hass et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Genetic analysis of the GABRA1 gene in patients with essential tremor
Hao Deng et al.
NEUROSCIENCE LETTERS (2006)
Topiramate in essential tremor - A double-blind, placebo-controlled trial
WG Ondo et al.
NEUROLOGY (2006)
Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications
FC Martin et al.
MOVEMENT DISORDERS (2005)
Genetic essential tremor in γ-aminobutyric acidA receptor α1 subunit knockout mice
JE Kralic et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Diazepam-induced changes on sleep and the EEG spectrum in mice:: role of the α3-GABAA receptor subtype
C Kopp et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Molecular and pharmacological characterization of GABAA receptor α1 subunit knockout mice
JE Kralic et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Drug interactions at GABAA receptors
ER Korpi et al.
PROGRESS IN NEUROBIOLOGY (2002)
A new benzodiazepine pharmacology
H Mohler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Is essential tremor predominantly a kinetic or a postural tremor? A clinical and electrophysiological study
KC Brennan et al.
MOVEMENT DISORDERS (2002)
Share Paper
